Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL

Trial Identifier: D133HR00022
Sponsor: AstraZeneca
Collaborator:
Hospital Israelita Albert Einstein
NCTID:: NCT05958134
Start Date: July 2023
Primary Completion Date: June 2024
Study Completion Date: June 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Brazil, Bahia Salvador, Bahia, Brazil, 40110-060
Brazil, Bahia Salvador, Bahia, Brazil, 41950-640
Brazil, Minas Gerais Belo Horizonte, Minas Gerais, Brazil, 30380-472
Brazil, Pernambuco Recife, Pernambuco, Brazil, 50070-902
Brazil, Rio de Janeiro Rio De Janeiro, Rio de Janeiro, Brazil, 20230-130
Brazil, Santa Catarina Florianópolis, Santa Catarina, Brazil, 88034-000
Brazil, São Paulo Botucatu, São Paulo, Brazil, 18618-686
Brazil, São Paulo São Paulo, Brazil, 05652-900
Brazil, São Paulo São Paulo, Brazil, 04378-500
Brazil, São Paulo São Paulo, Brazil, 1509-001